Systemic Sclerosis (SSc) research hub
6 indexed studies · 5 currently recruiting
- recruitingPHASE2
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
This study is testing a new medicine, tibulizumab, for an illness called systemic sclerosis (scleroderma). We want to see if it helps improve symptoms over 24 weeks, followed by an additional 28 weeks where everyone gets the study drug.
United States · Argentina · Chile - not yet recruiting
Ultrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR)
This study looks at how ultrasound scans of spit glands can help understand conditions like Sjögren's, lupus, and rheumatoid arthritis. Researchers want to see if these scans can tell the difference between these diseases and how they affect people with dry mouth.
France - active not recruitingPHASE3
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
This study, DAISY, is testing a new treatment called Anifrolumab for adults with Systemic Sclerosis (also known as Scleroderma). We want to see if it's safe and effective compared to a dummy treatment, to help improve symptoms and quality of life.
United States · Austria · Belgium - recruitingPHASE2, PHASE3
Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
This study is looking into whether a common blood-thinning medication called clopidogrel can help prevent a serious disease called systemic sclerosis (scleroderma) from developing in people who show early signs. It's an important step toward finding ways to stop this condition before it fully takes hold.
France - recruitingNA
Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre
This study looks at how scleroderma (a rare condition affecting skin and organs) changes over 5 years. Researchers collect blood and tissue samples to better understand this disease, as there is currently no cure. They hope to improve future treatments.
France - recruiting
Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma
This study looks at skin cells from people with scleroderma to understand how they contribute to the condition. Researchers want to learn more about a specific type of cell called fibroblasts, which are thought to play a key role in causing the skin to thicken and harden.
France